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Abstract 
In isolated rat anterior pituitary cells, KN-62 (10 /xM), an isoquinoline sulfonamide inhibitor of calcium/calmodulin-dependent 
protein kinase II, inhibited high KCI(50 mM)-stimulated prolactin secretion almost completely, with an IC5o of 95 nM. KN-62 inhibited 
TRH-induced prolactin secre, tion less effectively. KN-04, a compound that is over 100-fold less active in inhibiting purified 
calcium/calmodulin-dependent protein kinase II, also inhibited high KCl-stimulated prolactin secretion with an IC5o of 500 nM. KN-62 
and KN-04 (10 /xM) both inhibited high KCl-stimulated increases in intracellular Ca 2+ concentrations. We conclude that KN-62 and 
KN-04 inhibit activation of voltage-dependent calcium channels in anterior pituitary cells either directly or indirectly. 
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KN-62(1-[N,O-Bis(5-isoquinolinesulfonyl)-N-methyl- 
L-tyrosyl]-4-phenylpiperazine) belongs to the isoquinolone 
sulfonamide series of protein kinase inhibitors [1,2]. Pro- 
tein kinase assays using purified kinases showed that 
KN-62 inhibited the activity of CaM kinase II activity with 
high potency (K  i = 0.9/xM), but had no significant effect 
on the activity of cyclic AMP-dependent protein kinase, 
protein kinase C and myosin light chain kinase [2]. CaM 
kinase II has a wide tissue distribution and may be an 
important component in many calcium messenger systems 
[3-5]. As a result, KN-62 has been used in intact cells as a 
tool to investigate the role of this kinase and has been 
found to inhibit a whole range of physiological processes, 
including GABA release into cerebrospinal fluid [6], phos- 
phorylation and activation of tyrosine hydroxylase stimu- 
lated by high potassium concentrations (56 mM) in PC12 
Abbreviations: CaM kinase II, calcium/calmodulin-dependent protein 
kinase II; TRH, thyrotropin-releasing hormone; [Ca 2+ ]i, concentration f 
intracellular calcium ion. 
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cells [7], long-term potentiation in the hippocampus [8], 
cholinergic-stimulated secretion in parietal cells [9], insulin 
secretion in pancreatic islet /3 cells, RINm5F cells, and 
HIT cells [10-12], neurite outgrowth in neuroblastoma 
cells [13], and the rate of spontaneous beating in cultured 
fetal mouse cardiac myocytes [14]. 
We investigated effects of KN-62 on prolactin secretion 
and increases in [Ca2+] i stimulated by high potassium 
concentrations and TRH. We also used KN-04, (N-l(1- 
1 (P-(-isoquinolinsulfonyl)benzyl)-2-(4-phenylpiperazinyl)- 
ether)-5-isoquinolinsulfonamide), a compound that does 
not inhibit CaM kinase II activity. 
1. Materials and methods 
Isolation of rat anterior pituitary cells. Rat anterior 
pituitary cells were isolated from Sprague-Dawley female 
retired breeders (8-9 months old) by sequential digestion 
with trypsin and pancreatin [15]. 
Prolactin secretion. Isolated cells were cultured in a l : l  
mixture of Dulbecco's modified medium and Ham's  F10 
medium supplemented with 15% horse serum in a humidi- 
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fled atmosphere of 95% air and 5% CO 2 for three days. 
Then cells were washed with Ringer's solution before 
incubating with Ringer's solution plus KN-62 or KN-04 at 
the indicated concentrations for 60 min. The Ringer's 
solution had the following composition in mM: NaCI 120, 
KC1 4.8, KH2PO 4 1.2, NaHCO 3 20, CaC12 1.8, MgSO 4 
1.0, glucose 4, HEPES 10 (pH 7.4), and 1 mg/ml  bovine 
serum albumin. The medium was changed to fresh medium 
containing KN-62 or KN-04 and the stimulus for prolactin 
release (KC1 50 mM or TRH 0.1 p,M); medium and cells 
were collected after a 10-min incubation. It takes 2 h or 
more before newly synthesized prolactin is secreted from 
primary cultures [16], so the effects measured with this 
assay are primarily on release of previously synthesized 
hormone. Prolactin in the cells and medium was measured 
using radioimmunoassay reagents upplied by the National 
Hormone and Pituitary Program, the National Institute of 
Diabetes and Digestive and Kidney Diseases, the National 
Institute of Child Health and Human Development and the 
US Department of Agriculture. Prolactin secretion was 
expressed as the percent in the medium of total (medium 
plus intracellular) in the culture. All data are expressed in 
means + S.E.M.; statistical differences were determined by 
the multiple t-test, and P < 0.05 taken as significant. 
Indo-1 fluorescence measurements of [Ca 2 + ]i. Freshly 
isolated cells were loaded with indo-1 by incubating with 
indo-1 AM (10 /zM) for 30 min at 37 C [15,17]. Fluores- 
cence was measured in an SLM 4000C spectrofluorometer 
with excitation at 350 nm and emission detected at 390 nm 
and 475 nm. Cells were perifused in Ringer's buffer. KC1, 
100 raM, was given in pulses both before and after KN-62 
or KN-04 treatment. KN-62 or KN-04 was first dissolved 
in DMSO:ethanol (1:1, v:v) at 1 mM, and then diluted in 
perifusion buffer to 10 /zM. In control experiments, only 
vehicle (DMSO:EtOH, 0.5% each) was added. In all exper- 
iments the ratio of f390nm/f475nm was recorded, and 
subsequently normalized so that the ratio at time zero was 
1.00. 
"~' 25 25 
~o A * * B 
.,~ (9) (S) 
20 ITI * 20 
[] (6) 
O~'~15 I i 15 .g 
10 s0 
r~ (6) (4) 
o 
KN-62 TRH TRH KN-62 KC1 KCI 
+ + 
KN-62  KN-62 
Fig. 1. Effect of KN-62 (10 p,M) on prolactin release stimulated by TRH 
(0.1 /xM, Panel A) or KC1 (50 mM, Panel B). The data are the 
mean + S.E.M. of independent experiments, and the number of experi- 
ments is given in brackets. An asterisk above the bar indicates that the 
value is significantly different than the control (P < 0.05). 
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Fig. 2. Effect of KN-62 (Panel A) and KN-04 (Panel B) on prolactin 
release stimulated by KCI (50 raM). The data are the mean + S.E.M. of 3 
independent experiments. Filled symbols represent results from ceils 
stimulated with KC1, and open symbols, controls with no KCI or KN 
treatment. An asterisk above the point indicates that the value is signifi- 
cantly different han the value from cells with KCI and no KN-62 or 
KN-04 (P < 0.05). 
Materials. Indo-1 AM was purchased from Molecular 
Probes (Eugene, OR). TRH was from Abbott Laboratories 
(North Chicago, IL). KN-62 and KN-04 were synthesized 
as before [2,6]. 
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Fig. 3. Effect of KN-62 on KCl-induced increases in [Ca -~+ ]i in anterior 
pituitary cells. KC1 (100 raM) pulses were given as indicated by the 
arrowheads under the tracing; the duration in seconds of each pulse is 
indicated by the numerals above each pen. Vehicle (V) or KN-62 (10 
p,M) was given as indicated and was present until the end of the 
experiment. Both trace A and trace B are representative of 3 identical 
experiments, 
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2. Results 
In primary cultures of anterior pituitary cells, TRH (0.1 
/zM) stimulated prolactin secretion from a basal level of 
6.60 + 0.93 (percentage of total prolactin in the cultures) 
to 19.69 +_ 1.05 (P <0.05. Fig. 1A). KN-62 (10 /zM) 
alone reduced basal secretion to 2.83 + 1.10 (P  < 0.05); 
TRH-stimulated secretion still occurred in the presence of 
KN-62, but was reduced to 13.83 + 1.71 (P  < 0.05). At 
least part of the inhibition of TRH-induced secretion may 
be accounted for by the decrease in basal secretion. High 
KCI concentrations (50 raM) also stimulated prolactin 
secretion (from 5.74 + 1.0 to 19.01 + 0.84, P < 0.05), but 
this stimulation was completely inhibited by KN-62 (to 
4.94 + 0.12, Fig. 1B). 
The effect of KN-62 on KCl-induced prolactin secretion 
was dose-dependent, almost completely blocking stimula- 
tion at 1 /zM (Fig. 2A). These concentrations are similar to 
those that inactivate CaM kinase II in vitro [14]. KN-04, 
however, which does not inhibit CaM kinase II, does 
inhibit KCl-induced prolactin secretion (Fig. 2B). KN-04 
was less effective than KN-62; the half-maximal inhibitory 
concentrations were 500 nM and 95 nM, respectively (Fig. 
2). 
High KCI concentrations depolarize the cells and cause 
calcium entry through voltage-dependent calcium chan- 
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Fig. 4. Effect of KN-62 on KCl-induced increases in [Ca 2+ ]i in anterior 
pituitary cells. KC1 (100 mM) pulses at 2, 5, and 15 s were given as 
indicated by the arrowheads. The cells were perifused either with vehicle 
(V) alone or with KN-62 (10 #,M). Trace A is representative of 3 and 
trace B of 5 identical experiments. 
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Fig. 5. Effect of KN-04 on KCl-induced increases in [Ca 2+ ]i in anterior 
pituitary cells. KC1 (100 mM) pulses at 2, 5, and 15 s were given as 
indicated by the arrowheads. KN-04 (10 /~M) was given at the indicated 
time and was present until the end of the experiment. This trace is 
representative of three similar experiments. 
nels; in anterior pituitary cells, the rise in [Ca2+]i is 
completely dependent on extracellular Ca 2+ [17]. We ex- 
amined whether KN-62 could affect he increase in [Ca 2+ ]i 
in perifused cells. Data in Fig. 3 show that 5-s pulses of 
KC1 (100 mM) could elicit repetitive increases in [Ca 2+ ]i, 
represented by the fluorescence ratio f390/f475. The vehi- 
cle alone did not affect the [Ca 2+ ]i spikes (Fig. 3A), but 
KN-62 (10 /xM) was inhibitory (Fig. 3B). KN-62 was so 
effective that a 50-s pulse at the end of the perifusion 
elicited an increase in the f390/f475 ratio that was only 
37% of a 5-s pulse before KN-62 addition (Fig. 3B). 
KN-62 (10 /xM) could not completely abolish KCl-in- 
duced f390/f475 increases, and more extensive recruit- 
ment of the voltage-dependent calcium channels was able 
to overcome the KN-62 inhibition to some extent (Fig. 4). 
The magnitude of the increase in the f390/f475 ratio by 
KC1 pulses depended on the duration of the pulse. Pulses 
of 2, 5, and 15 s stimulated increasing spikes of [Ca 2+ ]i. 
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Fig. 6. The effect of KN compounds on KCl-induced [Ca 2+ ]i increases. 
Data from the experiments were combined by normalizing the increases 
in f390/f475 to the first 2-s KC1 pulse; the means+S.E.M, of the 
increases in the ratio that occurred with subsequent pulses are shown. 
Closed symbols represent increases with no additions and open symbols 
represent increases in the presence of KN-62 (Panel A, n = 5), vehicle 
(Panel B, n = 3), or KN-04 (Panel C, n = 3). 
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Neither the magnitude nor the duration of the [Ca2+]i 
increase was affected by vehicle alone (Fig. 4A). KN-62 
markedly diminished KCl-induced [Ca 2÷ ]i increases, but 
increasing the duration of the pulse did still increase 
[Ca2+ ]i (Fig. 4B). 
KN-04 had a similar effect on KCl-induced [Ca2+] i 
increases (Fig. 5). KN-04 (10 ~M) inhibited [Ca 2÷ ]i spikes 
of 2, 5, and 15 s pulses. The results of all the experiments 
with this time course are summarized in Fig. 6. KN-04, 
like KN-62, inhibited the increase in [Ca 2+ ]i, but was not 
quite as effective as KN-62. 
3. Discussion 
In rat pituitary cells, we found that 10 /xM KN-62 and 
KN-04 reduced the increase in [Ca 2+ ]i caused by activat- 
ing voltage-dependent Ca 2+ channels. Increases in [Ca2+] i 
trigger prolactin release and KN-62 and KN-04 also re- 
duced prolactin release triggered by activating voltage-de- 
pendent Ca 2÷ channels. These compounds did not reduce 
TRH-induced prolactin release to the same extent, and they 
had no effect on increases in [Ca2+]i caused by TRH 
pulses (data not shown). Although TRH stimulates Ca 2÷ 
entry [15], it also releases Ca 2÷ from intracellular stores 
[18], and causes formation of diacylglycerol [19]. Under 
the conditions of our experiments, these latter two factors 
may be of primary importance in contributing to prolactin 
release stimulated by TRH. 
One explanation for our data is an action of CaM kinase 
II on calcium channels. If CaM kinase II regulates 
voltage-dependent Ca 2+ channels to increase their activity 
in certain tissues, then decreasing the activity of CaM 
kinase II with inhibitors will decrease the ability of the 
enzyme to activate the channels. The chief argument against 
this model is that KN-04 has the same effect as KN-62, 
and KN-04 is not an effective inhibitor of purified CaM 
kinase II. KN-62 (1 /~M) inhibited purified CaM kinase II 
over 90%, and the K i was 0.1 /zM [14]. KN-04 (10 /xM) 
caused only 20% inhibition and the K i was 100 /zM [14]. 
We previously demonstrated that lactotrophs have CaM 
kinase II by immunoblots and immunocytochemistry [20]. 
It is possible that there is modification of the enzyme in 
pituitary cells to make it more sensitive to KN-04. We 
attempted to test this by measuring the effects of KN-04 
and KN-62 in homogenates of pituitary cells, using the 
phosphorylation f a peptide substrate as an assay [21]. We 
were unable to detect any significant inhibition by either 
compound under a variety of conditions. Although the 
pituitary cells may contain forms of CaM kinase II that 
cannot be inhibited by KN-62, it is also possible that the 
amount of homogenate we needed to use to detect activity 
contained enough endogenous calmodulin to competitively 
inhibit the action of KN-62 [2]. The concentration of 
KN-62 that we can use is limited by solubility and the 
effects of DMSO on the homogenate, and therefore these 
experiments with homogenates are not conclusive. The 
results in intact cells with KN-04, however, indicate that, if 
CaM kinase I1 is involved, the enzyme does not have the 
same inhibitor specificity in lactotrophs as it does in other 
tissue. 
Use of KN-04 has not been as widespread as KN-62; 
when it has been used it usually has had no effect 
[6,10,14,22-24]. There was a small effect on insulin re- 
lease; 5 /zM KN-62 inhibited glucose-stimulated insulin 
secretion 75%, and 10 /zM KN-04 inhibited this stimula- 
tion about 25% [10]. The data so far therefore indicate that 
hormone release from lactotrophs and possibly /3-cells of 
pancreatic islets are sensitive to KN-04, but muscle con- 
traction and neurotransmitter r lease are not. 
The simplest explanation for the decrease in K+-stimu - 
lated prolactin release and [Ca 2+ ]i caused by KN-62 and 
KN-04 is that these compounds affect the activity of 
voltage-dependent Ca 2÷ channels in anterior pituitary cells. 
KN-62 has a similar effect on insulin release as it does on 
prolactin release. In HIT insulin-producing cells, KN-62 
inhibits K+-stimulated insulin release and increases in 
[Ca2+]i [12]. KN-62 did not affect the increase in [Ca2+] i 
caused by bombesin in these cells [12]. The authors sug- 
gest that KN-62 directly inhibited L-type Ca 2÷ channels. 
More recent investigations, however, have indicated KN-62 
does not inhibit Ca 2+ channels in neurons and myocytes 
[23,25-27]. Therefore, at this time there is no evidence for 
a direct effect on Ca 2+ channels. 
The results of KN-62 on hormone release in lactotrophs 
differ from effects on muscle contraction and neurotrans- 
mitter elease in the inhibition of [Ca 2 ÷ ]i increases caused 
by voltage-dependent Ca 2+ channels. This tissue speci- 
ficity may be due to differences in Ca 2÷ channels. Pitu- 
itary cells have at least two types of calcium channels, L
and T channels [28,29]. T channels, activated at low 
membrane potentials, are not well characterized, but L 
channels, high voltage-activated channels, are made of 
oligomeric complexes of four different subunits, ce~, a 
complex of a 2 and ~, /3 and y. There are at least 6 genes 
coding for % subunits and 4 for /3 subunits; further 
diversity based on splice variants and post-translational 
processing lead to functional differences [30]. Tissue speci- 
ficity in the channels may explain the effects on [Ca 2+ ]i- 
Alternatively, the tissue specificity of the KN-62 may be 
that pituitary cells and possibly /3-cells of the pancreas 
have some process sensitive to KN-62 and KN-04 that 
indirectly inhibits Ca 2+ channel activity. 
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